UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM 8-K
____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 12, 2019 (September 11, 2019)
____________________
EXICURE, INC.
(Exact name of Registrant as specified in its charter)
____________________
Delaware 001-39011 81-5333008
(State or other jurisdiction
of incorporation) 		(Commission
File Number) 		(IRS Employer
Identification No.)
8045 Lamon Avenue
Suite 410
Skokie, IL 60077
(Address of principal executive offices)
Registrant’s telephone number, including area code: (847) 673-1700
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.0001 per share XCUR The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒




Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;   Compensatory Arrangements of Certain Officers.

On September 11, 2019, Dr. Shad Thaxton resigned from his position as a member of the Board of Directors of Exicure, Inc. (the “Company”), effective immediately.

In connection with this resignation, the Board of Directors (the “Board”) of the Company extended the period in which any vested stock option held by Dr. Thaxton may be exercised following Dr. Thaxton’s resignation from 90 days to one year, conditioned upon Dr. Thaxton agreeing, unless otherwise approved by the Board, not to sell any of the shares of common stock underlying such options for a period of 90 days following his resignation.

Item 8.01 Other Events.

On September 11, 2019, the Board adopted a policy changing the period in which vested stock options held by the Company’s directors may be exercised following a director’s departure from the Company from 90 days to one year following the last date of service of such director. Such extended exercise period is conditioned upon the director agreeing, unless otherwise approved by the Board, not to sell any of the shares of common stock underlying such options for a period of 90 days following his resignation.


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 12, 2019 EXICURE, INC.
By: /s/ David A. Giljohann
David A. Giljohann, Ph.D.
Chief Executive Officer